L-PRF in Osteoarthritis Treatment: Results of a Pilot Study

Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 6

Abstract

Osteoarthritis (OA) is the most common chronic musculoskeletal disorder and is the most frequent single cause of disability in older adults [1]. OA is a chronic disease progressively involving the entire joint. Progression involves capsule-bursa inflammation, synovial fluid modifications, cartilage erosions, and osteochondral inflammatory deteriorations leading to bone erosion and distortion [1]. Early OA defines the initial cascade of events that trigger the disease and lead to the full-blown OA. The disease progression can sometimes last for years being quite often neglected or mistreated with palliative medications. Joint resident MSCs has always been a target for our research into and treatment of OA [1,2,3]. Recently L-PRF (leukocyte and platelet-rich fibrin), showed promising properties in connective tissue regeneration and, for this reason, is now widely applied in chronic wound healing and jawbone growth [4,5,6]. After centrifugation, L-PRF membranes hold vital platelets, leukocytes, and various peripheral blood cells [7,8]. As a result, we exposed these membranes to a thermic shock aimed to increase the pool of HSPs. The final product was named supercharged L-PRF. Supercharged L-PRF components -membranes and hyper-acute serum- were used in knee OA patients in a small preliminary comparative study. 20 consecutive patients were randomly divided into 2 groups: 10 patients treated with supercharged L-PRF and 10 with PRP+HA (PRP+ Hyaluronic acid). The primary outcome of this study was to induce persistent pain relief and recovery of motility. This article reports supercharged L-PRF preliminary experience in degenerative OA treatment.

Authors and Affiliations

Valerio Di Nicola1,2*

Keywords

Related Articles

Alice in Wonderland Syndrome: An Update of Present Data with a Special View to Body Position, Traumatic and Genetic Aspects

Alice in Wonderland Syndrome (AIWS) was named after the description of Lewis Carroll in his novel. In 1955, John Todd, a psychiatrist described this entity for the first time and results in a distortion of perception. To...

COVID-19: Drug Delivery System, Drug Discovery and Therapy Options

Drug delivery system plays a vital part in destroying the pandemic. Few options on drug delivery is been highly considered. One such delivery is emulsifying system. This system plays important role in reducing water comp...

The Effectiveness of Amoxicillin and Cefalexin in Two Species from Staphylococcus and Bacillus Isolated from Bovine Mastitis in Sudan

In this study 60 milk samples collected from mastitic cows to isolates and identify bacterial agents. The percentage of isolates was as follows: Staphylococcus spp 52%, Bacillus spp 26%, Enteroccocispp 3%; microccus 3%...

COVID-19 in Adults and Children: The Clock is Ticking

COVID-19 the world is shocked. Globally, 896450 confirmed cases and 45525 deaths (WHO, situation report 73, 2 April 2020) reveal that a viral agent is spreading in an exponential way all around the world with to date unk...

Space Medicine Propelling Earth-Based Medicine for the Advantage of Human on Earth – A Vision Beyond 2020

What will be the future of medicine a decade from now? What difficulties related with preventing, detecting, and treating diseases will have been unraveled? How will space medicine make an impact? [1]. Today as compared...

Download PDF file
  • EP ID EP707351
  • DOI https://doi.org/10.37191/Mapsci-2582-385X-2(6)-048
  • Views 77
  • Downloads 0

How To Cite

Valerio Di Nicola1, 2* (2020). L-PRF in Osteoarthritis Treatment: Results of a Pilot Study. Journal of Regenerative Biology and Medicine, 2(6), -. https://europub.co.uk./articles/-A-707351